4:51 PM
Jan 10, 2017
 |  BC Innovations  |  Distillery Therapeutics


INDICATION: Heart failure

Patient sample and mouse studies suggest inhibiting LOXL2 could help treat heart failure. LOXL2 levels were higher in serum samples from heart failure patients and cardiac tissue samples from cardiomyopathy...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >